Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Research
Semarang, Jawa Tengah-based Pt. Sccr Indonesia operates in Research. Privately held, at sccr.id. It holds one address on record, all in Indonesia. It employs 72 people, on the record. It lists cancer and research among its specialties. It is listed alongside nine similar brands, mostly in Biotechnology Research.
Stem Cell and Cancer Research (SCCR) is an independent institution for research and pharmacy industries studies that was established in June 2013 by Prof. Dr. dr. Agung Putra, M.Si Med. SCCR scope of work covers a wide range of stem cell (regenerative medicine) and cancers stem cell issues, primarily from the research projects. We have 10 years of experience in collaboration research between faculties of clinical departments and basic medical scientists, in other to have an international competitiveness level in Indonesia. SCCR actively work to promote future medicine through research-based evidence. The SCCR is guided by the director and the head of each two main division which are the division of the fundamental and applied research.
| Countries | 1 |
|---|---|
| Primary country | ID |
All codes: ID
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
72 counted staff profiles at January 2026, inside the self-reported 51–200 band.
One address on record, Indonesia only. Primary: Semarang, Jawa Tengah 50222.
None linked to this brand.
Four tags on the brand's own list, among them cancer and research.
12 profiles list PT. SCCR INDONESIA as a peer — 92nd percentile in Research. It lists ten peers of its own. PT Prodia StemCell Indonesia and Biotis Pharmaceuticals Indonesia list it back.